Copyright & Licensing
Open access publishing for maximum research impact and author rights protection.
Creative Commons Licensing
Experimental and Clinical Toxicology publishes all articles under Creative Commons Attribution 4.0 International License (CC BY 4.0), enabling unrestricted sharing and adaptation with appropriate attribution to original authors.
Authors retain full copyright ownership of their published work. Unlike traditional subscription publishing where authors typically transfer copyright to publishers, our open access model ensures authors maintain all rights to their research. Authors may share, reuse, adapt, and build upon their published articles without seeking publisher permission.
Copyright retention means authors can freely distribute their published articles through personal websites, institutional repositories, preprint servers, and social media platforms. Authors may incorporate their published work into future publications, presentations, and educational materials without restriction.
Sharing
Anyone may copy and redistribute published articles in any medium or format for any purpose including commercial use. The open license removes barriers preventing research access and ensures toxicology findings reach all stakeholders who need them.
Adaptation
Others may remix, transform, and build upon published articles for any purpose. This enables translation into other languages, incorporation into derivative works, and development of educational resources based on published research.
Attribution
Users must give appropriate credit, provide link to the license, and indicate if changes were made. Attribution must include original authors, journal name, and DOI. No additional restrictions may be imposed beyond license terms.
CC BY 4.0 licensing meets open access requirements of major research funders worldwide. NIH Public Access Policy, Wellcome Trust Open Access Policy, UKRI Open Access Policy, and European Commission Horizon requirements are satisfied through immediate open access CC BY publication.
Authors funded by organizations with specific open access mandates should verify their publications comply with funder requirements. Our open access model with CC BY licensing provides maximum compatibility with current and anticipated funder policies promoting research accessibility.
Authors incorporating third-party content (figures, tables, text excerpts) must obtain appropriate permissions and provide attribution in accordance with original license terms. Authors should verify permissions cover open access publication under CC BY 4.0 before manuscript submission.
For content under restrictive licenses that cannot be included under CC BY 4.0, authors should consider creating original alternatives or obtaining specific written permission from rights holders. Third-party content permissions should be documented and available for verification.
Pre-Submission Copyright: Manuscripts representing original work not previously published and not under consideration elsewhere. Authors warrant they have authority to publish submitted content and have obtained necessary permissions for any third-party materials.
Questions About Licensing?
Contact our editorial team for copyright and licensing guidance.
Contact Editorial Office